1 Developing regional guidelines on minimum requirements for the registration of herbal medicinal products

2 WHO recommends that countries use multiple pricing policies to achieve low prices for generic and biosimilar medicines that are informed by the cost of production?. 1

Information on potential human exposure to a pesticide as a result of its proposed use in occupational and nonoccupational settings, data from poison control centres,

Of these medicines, the availability of originator brands was 15% and 23% in the public and private sectors, respectively; the availability most sold generics were 40% and 46%,

This WHO Quality Assurance Policy for the Procurement of Essential Medicines and other Health Products (the Policy) sets out the principles and requirements regulating WHO

The World Health Organization (WHO) wishes to express its sincere appreciation to the Regional Government of Lombardy, Italy, for kindly hosting the first WHO working group meeting

Inȱ 1999,ȱ Mongoliaȱ issuedȱ itsȱ nationalȱ policyȱ onȱ TM/CAMȱ inȱ theȱ “Stateȱ Policyȱ forȱ Developmentȱ ofȱ Mongolianȱ Traditionalȱ Medicine”.ȱ Noȱ

The substantial prior human use of traditional dose regi- mens of herbal medicines generally conveys reasonable confidence that these regimens can safely be administered to

The guidelines also set out proposals regarding the minimum regulatory requirements for the registration of each category of traditional medicine in terms of the quality